3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Myofibroma
1
Melanoma
1
Lung Neoplasms
1
Hepatic Tumor Resection
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholecystitis
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
13
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
3
Pirinitramide
2
Morphine
2
Bevacizumab
2
ribociclib
1
lanreotide
1
jinfukang
1
eribulin
1
cabazitaxel
1
Zoledronic Acid
1
Vinorelbine
1
Trastuzumab
1
Thiotepa
1
Taxes
1
Stem Cell Transplantation
1
Standard of Care
1
Spinal Puncture
1
Sorafenib
1
Radiofrequency Ablation
1
Propofol
1
Pemetrexed
1
Octreotide
1
Letrozole
1
Lapatinib
1
Injections, Epidural
1
Injections
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplastic Cells, Circulating
×
Desflurane
×
Clear all
NCT02335151
2019-12-13
CTC Pancreatic Adenocarcinoma
University of Zurich
Phase 4
Completed
86 enrolled